H-rGO-Pd NPs Nanozyme Enhanced Silver Deposition Strategy for Electrochemical Detection of Glypican-3
- PMID: 36903516
- PMCID: PMC10004744
- DOI: 10.3390/molecules28052271
H-rGO-Pd NPs Nanozyme Enhanced Silver Deposition Strategy for Electrochemical Detection of Glypican-3
Abstract
Glypican-3 (GPC3), as an emerging biomarker, has been shown to be beneficial for the early diagnosis and treatment of hepatocellular carcinoma (HCC). In this study, an ultrasensitive electrochemical biosensor for GPC3 detection has been constructed based on the hemin-reduced graphene oxide-palladium nanoparticles (H-rGO-Pd NPs) nanozyme-enhanced silver deposition signal amplification strategy. When GPC3 specifically interacted with GPC3 antibody (GPC3Ab) and GPC3 aptamer (GPC3Apt), an "H-rGO-Pd NPs-GPC3Apt/GPC3/GPC3Ab" sandwich complex was formed with peroxidase-like properties which enhanced H2O2 to reduce the silver (Ag) ions in solution to metallic Ag, resulting in the deposition of silver nanoparticles (Ag NPs) on the surface of the biosensor. The amount of deposited Ag, which was derived from the amount of GPC3, was quantified by the differential pulse voltammetry (DPV) method. Under ideal circumstances, the response value was linearly correlated with GPC3 concentration at 10.0-100.0 μg/mL with R2 of 0.9715. When the GPC3 concentration was in the range from 0.01 to 10.0 μg/mL, the response value was logarithmically linear with the GPC3 concentration with R2 of 0.9941. The limit of detection was 3.30 ng/mL at a signal-to-noise ratio of three and the sensitivity was 1.535 μAμM-1cm-2. Furthermore, the electrochemical biosensor detected the GPC3 level in actual serum samples with good recoveries (103.78-106.52%) and satisfactory relative standard deviations (RSDs) (1.89-8.81%), which confirmed the applicability of the sensor in practical applications. This study provides a new analytical method for measuring the level of GPC3 in the early diagnosis of HCC.
Keywords: Glypican-3; H-rGO-Pd NPs nanozyme; electrochemical nanobiosensor; hepatocellular carcinoma; peroxidase-like catalytic silver deposition.
Conflict of interest statement
The authors declare no conflict of interest.
Figures





Similar articles
-
Glypican-3 electrochemical aptamer nanobiosensor based on hemin/graphene nanohybrids peroxidase-like catalytic silver deposition.Mikrochim Acta. 2020 Apr 30;187(5):305. doi: 10.1007/s00604-020-04284-w. Mikrochim Acta. 2020. PMID: 32356075
-
A label-free electrochemical aptasensor based on platinum@palladium nanoparticles decorated with hemin-reduced graphene oxide as a signal amplifier for glypican-3 determination.Biomater Sci. 2022 Nov 22;10(23):6804-6817. doi: 10.1039/d2bm01134d. Biomater Sci. 2022. PMID: 36317566
-
A sandwich-type electrochemical sensor based on RGO-CeO2-Au nanoparticles and double aptamers for ultrasensitive detection of glypican-3.Mikrochim Acta. 2024 Oct 19;191(11):681. doi: 10.1007/s00604-024-06704-7. Mikrochim Acta. 2024. PMID: 39427046
-
Ag and Au nanoparticles/reduced graphene oxide composite materials: Synthesis and application in diagnostics and therapeutics.Adv Colloid Interface Sci. 2019 Sep;271:101991. doi: 10.1016/j.cis.2019.101991. Epub 2019 Jul 17. Adv Colloid Interface Sci. 2019. PMID: 31376639 Review.
-
Glypican 3-Targeted Therapy in Hepatocellular Carcinoma.Cancers (Basel). 2019 Sep 10;11(9):1339. doi: 10.3390/cancers11091339. Cancers (Basel). 2019. PMID: 31510063 Free PMC article. Review.
Cited by
-
Carbon-Based Enzyme Mimetics for Electrochemical Biosensing.Micromachines (Basel). 2023 Sep 7;14(9):1746. doi: 10.3390/mi14091746. Micromachines (Basel). 2023. PMID: 37763909 Free PMC article. Review.
-
Recent Advances in Functional Nanomaterials for Electrochemical Sensors and Biosensors.Molecules. 2023 Sep 25;28(19):6798. doi: 10.3390/molecules28196798. Molecules. 2023. PMID: 37836641 Free PMC article.
-
Nanozyme-based aptasensors for the detection of tumor biomarkers.J Biol Eng. 2025 Feb 7;19(1):13. doi: 10.1186/s13036-025-00485-0. J Biol Eng. 2025. PMID: 39920818 Free PMC article. Review.
-
Preclinical advance in nanoliposome-mediated photothermal therapy in liver cancer.Lipids Health Dis. 2025 Jan 31;24(1):31. doi: 10.1186/s12944-024-02429-x. Lipids Health Dis. 2025. PMID: 39891269 Free PMC article. Review.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources